Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus
Stohl, William, Hiepe, Falk, Latinis, Kevin M., Thomas, Mathew, Scheinberg, Morton A., Clarke, Ann, Aranow, Cynthia, Wellborne, Frank R., Abud-Mendoza, Carlos, Hough, Douglas R., Pineda, Lilia, Migone, Thi-Sau, Zhong, Z. John, Freimuth, William W., Chatham, W. Winn
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.07.2012)
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.07.2012)
Get full text
Journal Article
Efficacy and safety of rituximab in moderately‐to‐severely active systemic lupus erythematosus: The randomized, double‐blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
Merrill, Joan T., Neuwelt, C. Michael, Wallace, Daniel J., Shanahan, Joseph C., Latinis, Kevin M., Oates, James C., Utset, Tammy O., Gordon, Caroline, Isenberg, David A., Hsieh, Hsin‐Ju, Zhang, David, Brunetta, Paul G.
Published in Arthritis and rheumatism (01.01.2010)
Published in Arthritis and rheumatism (01.01.2010)
Get full text
Journal Article
Effect of belimumab on vaccine antigen antibodies to influenza, pneumococcal, and tetanus vaccines in patients with systemic lupus erythematosus in the BLISS-76 trial
Chatham, W Winn, Wallace, Daniel J, Stohl, William, Latinis, Kevin M, Manzi, Susan, McCune, W Joseph, Tegzová, Dana, McKay, James D, Avila-Armengol, Hilario E, Utset, Tammy O, Zhong, Z John, Hough, Douglas R, Freimuth, William W, Migone, Thi-Sau
Published in Journal of rheumatology (01.08.2012)
Published in Journal of rheumatology (01.08.2012)
Get more information
Journal Article
Stress-Induced Fas Ligand Expression in T Cells Is Mediated through a MEK Kinase 1-Regulated Response Element in the Fas Ligand Promoter
Faris, Mary, Latinis, Kevin M., Kempiak, Stephan J., Koretzky, Gary A., Nel, Andre
Published in Molecular and Cellular Biology (01.09.1998)
Published in Molecular and Cellular Biology (01.09.1998)
Get full text
Journal Article
14. Immunologic rheumatic disorders
Brasington, Richard D., Kahl, Leslie E., Ranganathan, Prabha, Latinis, Kevin M., Velazquez, Celso, Atkinson, John P.
Published in Journal of allergy and clinical immunology (01.02.2003)
Published in Journal of allergy and clinical immunology (01.02.2003)
Get full text
Journal Article
The Regulation of CD95 (Fas) Ligand Expression in Primary T Cells: Induction of Promoter Activation in CD95LP-Luc Transgenic Mice
Norian, Lyse A, Latinis, Kevin M, Eliason, Steve L, Lyson, Krzysztof, Yang, Chunmei, Ratliff, Timothy, Koretzky, Gary A
Published in The Journal of immunology (1950) (01.05.2000)
Published in The Journal of immunology (1950) (01.05.2000)
Get full text
Journal Article
Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events
Latinis, KM, Carr, LL, Peterson, EJ, Norian, LA, Eliason, SL, Koretzky, GA
Published in The Journal of immunology (1950) (15.05.1997)
Published in The Journal of immunology (1950) (15.05.1997)
Get full text
Journal Article
Belimumab Reduces Autoantibodies, Normalizes Low Complement, and Reduces Select B-Cell Populations in Patients With Systemic Lupus Erythematosus
STOHL, WILLIAM, HIEPE, FALK, LATINIS, KEVIN M., THOMAS, MATHEW, SCHEINBERG, MORTON A., CLARKE, ANN, ARANOW, CYNTHIA, WELLBORNE, FRANK R., ABUD-MENDOZA, CARLOS, HOUGH, DOUGLAS R., PINEDA, LILIA, MIGONE, THI-SAU, ZHONG, Z. JOHN, FREIMUTH, WILLIAM W., CHATHAM, W. WINN
Published in Arthritis and rheumatism (01.07.2012)
Published in Arthritis and rheumatism (01.07.2012)
Get full text
Journal Article
Signaling Events in T Lymphocytes Leading to Cellular Activation or Programmed Cell Death
Musci, Michael A., Latinis, Kevin M., Koretzky, Gary A.
Published in Clinical immunology and immunopathology (01.06.1997)
Published in Clinical immunology and immunopathology (01.06.1997)
Get full text
Journal Article